Background {#Sec1}
==========

Acute kidney injury (AKI) is a common complication in burn patients admitted to the intensive care unit (ICU), but incidence rates depend upon the burn population studied and AKI definition used \[[@CR1], [@CR2]\]. Consensus definitions of AKI are developed to include all severities of AKI and allow comparison between studies; these are the Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE) \[[@CR3]\]; Acute Kidney Injury Network (AKIN) \[[@CR4]\]; and Kidney Disease: Improving Global Outcomes (KDIGO) criteria \[[@CR5]\].

Several risk factors for AKI are identified in burn patients such as high age, burn injury extent and/or mechanism, and presence of multiple organ failure and/or sepsis \[[@CR2]\]. However, the results of prophylactic strategies have so far mostly been disappointing \[[@CR6]\]. AKI is a heterogeneous condition ranging from subclinical decline in kidney function to need of renal replacement therapy (RRT). Despite development of international treatment guidelines \[[@CR5]\], the practical handling of AKI, and use of RRT, varies substantially across the world \[[@CR7]\].

AKI in burn patients is associated with increased mortality \[[@CR2], [@CR8]\] and probably also increased length of stay (LOS) \[[@CR2]\]. From other patient groups, it has become evident that survivors of AKI are prone to developing chronic kidney disease (CKD) and have increased long-term morbidity and mortality \[[@CR9]\]. AKI may also be a burden to the health care system, leading to substantially increased treatment costs, especially related to use of RRT \[[@CR10]\].

The purpose of the present study was to review incidence, risk factors, and outcomes of AKI in burn patients admitted to the ICU. Secondary aims were to review the use of renal replacement therapy (RRT) and impact on health care costs.

Methods {#Sec2}
=======

Study registration {#Sec3}
------------------

This systematic review and meta-analysis was registered in the PROSPERO database on 12 May 2017 (CRD42017060420) \[[@CR11]\]. We report results according to the PRISMA guidelines (Additional file [1](#MOESM1){ref-type="media"}).

Data sources and search strategy {#Sec4}
--------------------------------

We searched papers published between 1 January 2004 and 3 December 2018 in PubMed, UpToDate, and National Institute for Health and Care Excellence (NICE). All reviews in Cochrane Database of Systematic Reviews except protocols were added to the PubMed search. Searches in PubMed consisted of Medical Subject Headings and text words including acute kidney injury and burn. We searched for ongoing systematic reviews in PROSPERO and conducted hand searches of reference lists.

The search focused on the study population, irrespective of reported intervention, comparison, and outcome. Inclusion was limited to studies of burn patients admitted to an ICU, reporting on AKI as defined by full or modified RIFLE, AKIN, and/or KDIGO criteria. Only publications in English or Scandinavian languages were considered (Additional file [2](#MOESM2){ref-type="media"}).

Study selection {#Sec5}
---------------

Two collaborators (KMN and CKT) independently screened studies for eligibility according to pre-defined study selection criteria (Additional file [3](#MOESM3){ref-type="media"}). Titles, abstracts, and keywords were examined, and full texts were obtained for all potentially relevant records. Studies on trauma patients without burns were excluded as findings are presented elsewhere \[[@CR12]\]. Empirical studies comparing AKI and non-AKI patients were included; case reports excluded. Any disagreement was resolved through discussion with a senior author (SB).

Data extraction {#Sec6}
---------------

Two independent collaborators (TF and SB) extracted data in duplicate according to a pre-defined data extraction form (Additional file [4](#MOESM4){ref-type="media"}). In cases where data points were missing or ambiguously reported, the first and last author of the study were contacted by e-mail up to two times to obtain data. For each study, we extracted detailed information about study sampling, i.e. if the patients were recruited consecutively from an intensive care unit or if the study sample was more narrowly defined.

We extracted data on days to AKI, criteria used, incidence rates, and severity including use of RRT. Many risk factors were assessed, including body mass index (BMI), mean arterial pressure (MAP), Total Body Surface Area (TBSA) percent burnt \[[@CR13]\], Abbreviated Burn Severity Index (ABSI) \[[@CR14]\], Simplified Acute Physiology Score (SAPS) \[[@CR15]\], Acute Physiology and Chronic Health Evaluation (APACHE) \[[@CR16]\] score, and Sequential Organ Function Assessment (SOFA) score \[[@CR17]\] (Additional file [5](#MOESM5){ref-type="media"}). Collected outcome data were renal recovery, ICU and hospital LOS, and mortality.

Assessment of study quality {#Sec7}
---------------------------

Two authors (TF and SB) independently assessed the risk of bias of each included study using the Newcastle-Ottawa quality assessment scale \[[@CR18]\].

Quantitative data synthesis {#Sec8}
---------------------------

Meta-analyses and forest plots were prepared in R \[[@CR19]\] using the meta \[[@CR20]\] and the forest plot \[[@CR21]\] packages. We used random effect models with the DerSimonian-Laird estimator since we expected some heterogeneity between studies. Continuous and dichotomous risk factors and outcomes were compared in patients with and without AKI by calculating mean differences (MD) and odds ratios (OR), respectively. Data primarily reported as medians with interquartile ranges were re-expressed into means and standard deviations (SDs) as suggested in the Cochrane handbook \[[@CR22]\]. Studies reporting distribution of data only as ranges were excluded from the meta-analyses.

Meta-analyses of proportions were performed on arcsine-transformed data. In an attempt to limit in-between study heterogeneity, it was decided post hoc that meta-analyses of proportions should be confined to studies applying consecutive or random data sampling methods. In contrast, all studies were included in meta-analyses based on the use of control groups.

Risk factors potentially associated with development of AKI were explored in pooled analyses if reported in three or more studies. We generated a forest plot containing summary estimates for multiple risk factors. For dichotomous risk factors, ORs were calculated using the meta package in R. Continuous risk factors were expressed as standardised mean differences (SMDs) using the meta package in R and transformed to OR according to the formula suggested in the Cochrane handbook \[[@CR23]\].

Subgroup analyses {#Sec9}
-----------------

We analysed subgroups on mild (RIFLE R, AKIN 1, KDIGO 1), moderate (RIFLE I, AKIN 2, KDIGO 2), and severe (RIFLE F, AKIN 3, KDIGO 3) AKI, and use of RRT.

Evaluation of heterogeneity {#Sec10}
---------------------------

Statistical heterogeneity among studies was assessed with Cochran's *Q* test \[[@CR22]\] and quantified by the *I*^2^ statistic describing the proportion of total variation due to heterogeneity rather than chance \[[@CR24], [@CR25]\].

Results {#Sec11}
=======

Study selection {#Sec12}
---------------

We identified 1106 unique studies from the literature search and screened their abstracts. Thirty-three of 286 potentially eligible studies were included in the qualitative and quantitative data synthesis \[[@CR26]--[@CR58]\] (Fig. [1](#Fig1){ref-type="fig"}). We requested additional data from the authors of nine publications, whereof four provided data \[[@CR47], [@CR55], [@CR56], [@CR58]\], one did not have the data \[[@CR36]\], and four did not respond \[[@CR35], [@CR51], [@CR52], [@CR54]\]. Fig. 1Flow chart of search results according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) guidelines. ICU, intensive care unit; AKI, acute kidney injury

Study characteristics {#Sec13}
---------------------

All 33 included studies were observational with cohort design published in medical journals with English language in article or letter form. Most studies were on adults with variable burn mechanism and extent. AKI criteria were RIFLE, AKIN, and KDIGO in 18, seven and eight studies, respectively. Eleven studies used original AKI criteria, whereas the remaining used different versions of modified criteria (*n* = 20), or did not describe the use of criteria (*n* = 2) (Table [1](#Tab1){ref-type="table"}). Table 1Characteristics of included studies on acute kidney injury in burn patientsFirst author, publication yearPopulation studied^a^Consecutive samplingAKI criteriaCriteria adherenceStudy designFollow-up time AKI^b^*N*, AKI/totalLopes JA, 2007Adults, severeNoRIFLEOriginalPCS10 daysn.a.Coca SG, 2007Adults, \> 10%YesRIFLEModified^c^RCSHospital81/304Steinvall I, 2008Adults, \> 20%YesRIFLEOriginalPCSHospital31/127Mariano F, 2008Adults, severeNoRIFLEUnknownPCS19 daysn.a.Palimeri T, 2009Children, \> 10%YesRIFLEModified^d^RCSHospital56/123Palimeri T, 2010Adults, \> 20%YesRIFLEOriginalRCSIntensive32/60Mosier MJ, 2010Adults, \> 20%NoRIFLEModified^e^RCS24 hn.a.Schneider DF, 2012Adults, \> 20%NoRIFLEModified^e^RCS48 hn.a.Chung KK, 2012Adults, unknownYesAKINModified^c^RCSHospital656/1973Hu JY, 2012Adults, \> 30%YesRIFLEOriginalRCSHospital151/396Stewart IJ, 2013Adults, burn ICUNoAKINModified^c^RCSHospitaln.a.Hong DY, 2013Adults, \> 20%YesRIFLEOriginalPCSHospital11/45Yang HT, 2014Adults, \> 20%YesRIFLEModified^e^PCS5 days31/66Yavuz S, 2014Children, \> 10%NoRIFLEOriginalPCS48 hn.a.Noshad H, 2014Adults, unknownNoRIFLEUnknownPCSUnknownn.a.Howell E, 2015Adults, \> 20%NoRIFLEModified^e^PCS48 hn.a.Sen S, 2015Adults, \> 20%NoRIFLEModified^f^PCS7 daysn.a.Ren H, 2015Adults,\> 10%NoKDIGOModified^e,g^PCS48 hn.a.Liang I, 2015Adults, \> 40%NoRIFLEModified^e^PCS2 daysn.a.Yim H, 2015Adults, majorYesAKINOriginalPCS28 days40/97Kym D, 2015Adults, \> 20%YesRIFLEOriginalPCSIntensive48/85Queiroz LF, 2016Adults, burn ICUYesKDIGOModified^c^RCSIntensive77/293Rakkolainen I, 2016Adults, \> 15%YesAKINModified^c^PCSIntensive9/19Sanches-Sanches M, 2016Adults, \> 15%NoAKINOriginalPCSIntensiven.a.Kuo G, 2016Adults, severeYesKDIGOModified^e^RCS3 days52/145Hundeshagen G, 2017Mix, burn centreYesKDIGOModified^c^RCS7 days88/718Kumar AB, 2017Adults, \> 20%NoAKINModified^c^RCS5 daysn.a.Kimmel LA, 2018Adults, \> 10%YesRIFLEModified^c^RCSUnknown60/267Chun W, 2018Adults, \> 20%YesAKINOriginalPCS28 days32/76Depret F, 2018Adults, \> 20%YesKDIGOOriginalPCSHospital55/87Talizin TB, 2018Adults, \> 20%NoKDIGOModified^c^PCS7 daysn.a.Kim HY, 2019Adults, surgeryNoKDIGOModified^c^RCS7 daysn.a.Clark AT, 2019Adults, burn ICUYesKDIGOModified^c^RCSHospital601/1040*AKI* acute kidney injury, *N* number, *RIFLE* Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease, *AKIN* Acute Kidney Injury Network, *KDIGO* Kidney Disease: Improving Global Outcomes, *PCS* prospective cohort study, *RCS* retrospective cohort study, *ICU* intensive care unit, *n.a* not applicable^a^Numbers are percent burn injury of Total Body Surface Area^b^Numbers are minimal follow-up time for AKI^c^Study used only creatinine criteria and not urine output criteria^d^Study used paediatric version of criteria^e^Study used shorter follow-up time than the criteria^f^Study only used injury and failure according to RIFLE criteria^g^Study only used serum creatinine increase ≥ 26.5 μmol/L within 48 h

The included studies comprised data from 8200 patients, and 18 of the studies had consecutive sampling of patients. In six of the papers, we selected only patients who had comparison between AKI and non-AKI (Table [1](#Tab1){ref-type="table"}). Most studies reported mean or median age between 30 and 60 years. Male participants ranged from 54 to 100%, and average TBSA percent burnt ranged from 16 to above 70%.

Assessment of study quality {#Sec14}
---------------------------

Overall study quality, scored according to the Newcastle-Ottawa scale, was moderate. The study population consisted of unselected major burn patients in 25 studies, and all studies had comparable control groups. Eleven studies excluded patients with CKD, and 20 studies omitted patients on chronic RRT. Twenty-three studies controlled for confounding factors when comparing groups. Eight of the studies had too short, or undescribed, follow-up time for AKI to occur. Assessment of outcomes was overall satisfactory, but only one study explicitly reported loss to follow-up (Additional file [6](#MOESM6){ref-type="media"}). No studies were excluded from our quantitative synthesis due to high risk of bias.

Quantitative data synthesis {#Sec15}
---------------------------

### Incidence rates {#Sec16}

Pooled analysis of 18 studies (5921 patients) with consecutive sampling of patients revealed an overall incidence of AKI of 38 (30--46) % (Fig. [2](#Fig2){ref-type="fig"}). Time from burn injury to AKI diagnosis ranged from 1 to 17 days \[[@CR36], [@CR37], [@CR45], [@CR46], [@CR53]\]. In the 13 studies reporting incidence rates by AKI severity, 10 (4--18) %, 8 (6--11) %, and 13 (10--17) % had mild, moderate, and severe AKI, respectively (Additional files [7](#MOESM7){ref-type="media"}, [8](#MOESM8){ref-type="media"}, and [9](#MOESM9){ref-type="media"}). Fig. 2Reported incidence rates of acute kidney injury (AKI) in burn patients admitted to the intensive care unit. *N*, number of patients in the study; CI, confidence interval; RE, random effect

### Risk factors {#Sec17}

Risk factors for AKI were reported in 29 studies with 7229 patients (Additional file [5](#MOESM5){ref-type="media"}), and pooled analyses yielded crude effect estimates for the different risk factors. High age, chronic hypertension, diabetes mellitus, high TBSA percent burnt, high ABSI score, inhalation injury, rhabdomyolysis, surgery, high APACHE II score, high SOFA score, sepsis, and mechanical ventilation were associated with increased risk of AKI (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Risk factors for acute kidney injury in burn patients admitted to the intensive care unit. The contribution from the various risk factors were statistically weighted and adjusted to a single scale. Odds ratios (OR) for continuous risk factors were derived from standardised mean differences. CI, confidence interval; ABSI, Abbreviated Burn Severity Index; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Function Assessment; TBSA, Total Body Surface Area; BMI, body mass index; MAP, mean arterial pressure

We were unable to quantify the impact of several relevant risk factors because they were reported in fewer than three studies; these included African American descent, body weight, pre-existing coronary artery disease, congestive heart failure and liver failure, SAPS II score, intraabdominal hypertension, circulatory shock, hypotension, number and duration of surgical procedures, and escharotomy (Additional file [5](#MOESM5){ref-type="media"}). Additional risk factors could not be analysed because studies reported zero events in both groups; these were pre-existing kidney disease, abdominal compartment syndrome, and chemical injury. Studies reporting median age were excluded because the conversion of median values to means tended to overestimate the risk association. Use of mechanical ventilation and ventilator time were correlated, and we report the use of mechanical ventilation.

### Renal replacement therapy {#Sec18}

RRT was reported in 13 studies (4357 patients) with consecutive sampling of patients and used in 12 (8--16) % of all burn patients (Additional file [10](#MOESM10){ref-type="media"}). RRT modes were continuous RRT \[[@CR38], [@CR45], [@CR46], [@CR54], [@CR55]\], intermittent haemodialysis \[[@CR47]\], or unspecified \[[@CR27], [@CR28], [@CR34], [@CR37], [@CR48], [@CR50], [@CR58]\].

### Length of stay {#Sec19}

Nine studies (3069 patients) reported ICU LOS, and 13 studies (4694 patients) hospital LOS. Patients with AKI had 8.6 (4.0--13.2) days longer ICU LOS (Additional file [11](#MOESM11){ref-type="media"}) and 10.5 (4.8--16.3) days longer hospital LOS (Additional file [12](#MOESM12){ref-type="media"}), compared to non-AKI patients.

### Mortality {#Sec20}

Pooled analysis of 16 studies (1872 AKI patients) revealed that mortality in AKI patients was 43 (32--56) %, but varied considerably across studies (Additional file [13](#MOESM13){ref-type="media"}). Mortality was much higher in AKI compared to non-AKI patients, with an OR of 11.3 (7.3--17.4) (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Mortality in burn patients with acute kidney injury (AKI) in the intensive care unit. Odds ratio (OR) for mortality reported at any time point is compared in AKI and non-AKI patients. N AKI, number of AKI patients; CI, confidence interval; RE, random effect

### Renal recovery {#Sec21}

Renal recovery was reported in two studies (42 AKI patients) with consecutive sampling of patients (Additional file [14](#MOESM14){ref-type="media"}), and all patients except two had normal kidney function at discharge \[[@CR28], [@CR37]\].

### Health care costs {#Sec22}

None of the studies reported health care costs of AKI.

### Subgroup analyses {#Sec23}

Seven studies (886 AKI patients) reported mortality in the different AKI severity groups. Pooled mortality in mild, moderate, and severe AKI was 14 (7--24) %, 21 (8--38) %, and 67 (51--81) % (Additional files [15](#MOESM15){ref-type="media"}, [16](#MOESM16){ref-type="media"}, and [17](#MOESM17){ref-type="media"}), respectively. AKI compared to non-AKI patients had OR for death of 3.9 (2.0--7.5), 11.1 (5.6--21.6), and 43.0 (23.5--78.8) in mild, moderate, and severe AKI, respectively (Additional files [18](#MOESM18){ref-type="media"}, [19](#MOESM19){ref-type="media"}, and [20](#MOESM20){ref-type="media"}).

Five studies (175 RRT patients) reported that patients undergoing RRT had a mortality rate of 74 (58--87) % (Additional file [21](#MOESM21){ref-type="media"}). Six studies (200 RRT patients) revealed that RRT patients had OR for mortality 60.4 (20.1--181.5) compared to non-AKI patients (Additional file [22](#MOESM22){ref-type="media"}).

### Sensitivity analyses {#Sec24}

It was decided post hoc that meta-analyses of proportions should be confined to studies that applied consecutive or random data sampling methods, and we therefore performed sensitivity analyses in which all studies were included. Briefly, the results remain similar even though all studies were included. For example, the incidence of AKI remained 38% and mortality among AKI patients remained 43% when all studies were included in the meta-analysis.

### Heterogeneity {#Sec25}

Heterogeneity varied considerably between the meta-analyses. Extensive heterogeneity with Cochran's *Q* test *p* \< 0.0001 and Higgins' *I*^2^ \> 90% was observed in most meta-analyses of proportions. Cochran's *Q* test also indicated heterogeneity in most analyses of rates and differences, but usually with lower Higgins' *I*^2^ scores. *I*^2^ was 72% when comparing mortality between AKI and no AKI groups and 77% for the analysis of ICU LOS. It is likely that a large part the observed heterogeneity can be attributed to differences between the available study samples. For example, we show that the mortality increases with the severity of AKI, but the distribution of AKI severity is unknown in many studies. The presence and absence of other risk factors also vary considerably between the included studies, but these differences are difficult to control for without access to individual patient data.

Discussion {#Sec26}
==========

This systematic review reveals that AKI occurs in approximately 38% of burn patients admitted to the ICU, with use of RRT in 12% of all patients. Burn patients at risk for AKI have high age, chronic hypertension, diabetes mellitus, high TBSA percent burnt, high ABSI score, inhalation injury, rhabdomyolysis, surgery, high APACHE II score, high SOFA score, sepsis, and mechanical ventilation. Development of AKI after burn is associated with prolonged stay in ICU and hospital, and reduced chance of survival. Kidney function seems to recover well in most burn patients with AKI. Notably, no study reported the economic consequences of AKI after burns.

A previous study of mixed ICU patients observed that 57% of the patients experienced AKI according to the KDIGO criteria, and 13.5% underwent RRT \[[@CR59]\]. In a meta-analysis of burn patients assessed by the RIFLE criteria, AKI was present in 30--66% of the patients, and RRT used in 5% \[[@CR8]\]. In comparison, this systematic review using several criteria revealed 38% with AKI and 12% treated with RRT. The incidence of AKI and use of RRT varied widely among the included studies; this may partly be explained by large differences in burn populations. It is likely, however, that many of the studies in this systematic review underreported the incidence of AKI due to the use of modified AKI criteria.

High age, chronic hypertension, and diabetes mellitus are known risk factors for AKI \[[@CR12], [@CR59]\]. An earlier meta-analysis found that inhalation injury, high TBSA percent burnt, and high ABSI score were risk factors for AKI after burn \[[@CR2]\]. Our data suggest that rhabdomyolysis and surgery are additional burn-related risk factors. AKI is often present in the most severely ill patients as indicated by high APACHE II and SOFA scores \[[@CR2], [@CR12]\]. Sepsis and use of mechanical ventilation have also previously been associated with increased risk of AKI in critically ill patients \[[@CR2], [@CR60], [@CR61]\].

AKI in ICU patients is often part of multiple organ failure \[[@CR1], [@CR62], [@CR63]\]. In line with this, we observed that patients with AKI had more than one week longer ICU and hospital LOS compared to non-AKI patients. A similar observation was recently observed in a meta-analysis of major trauma patients \[[@CR12]\]. The effect on LOS in our systematic review may be underestimated, since patients with AKI might have a high early mortality not adjusted for in many of the included studies.

In the present study, AKI after burns was associated with several-fold increased mortality that was worsened with the severity of AKI disease. A previous systematic review of burn patients with AKI according to the RIFLE criteria reported a mortality rate of 35% \[[@CR8]\]. When applying several AKI criteria, we found that 43% of burn patients with AKI died, and 74% of patients undergoing RRT. In comparison, mortality was 27% in a study of general ICU patients with AKI \[[@CR59]\].

Evaluation of renal recovery is challenging because the definition may vary from full recovery of functional reserve to RRT independence \[[@CR64]\]. In our systematic review, only two studies with consecutive sampling of patients reported renal recovery; these reported that all patients except two had normal kidney function at discharge. This finding should be interpreted with caution due to limited number of patients and insufficient follow-up time to evaluate long-term effects. Previous research suggests that ICU patients with AKI have increased risk of CKD and all-cause mortality compared to patients without AKI \[[@CR9]\].

None of the studies reported the economic consequences of AKI after burns. Despite this, one would assume that both prolonged LOS and use of RRT would increase treatment costs \[[@CR65]\].

This systematic review has a number of clinical limitations. The included studies had large clinical heterogeneity because the study participations and outcome variables varied widely. AKI incidence may be underestimated since many studies used modified AKI criteria. Creatinine levels and urine output are influenced by fluid and/or diuretic therapy not reported in most of the studies. Data on hospital and ICU outcomes are influenced by the local policy for transfer of patients, withholding or withdrawing therapy. The handling of AKI, and particularly the use of RRT, probably varied across sites \[[@CR66]\]. Finally, the applicability of the results on renal recovery may be impaired by variable case definitions and short follow-up times.

Methodological limitations are that some publications may have been missed due to language limitation of the literature search. Complete datasets could not be obtained from five studies. Many of our meta-analyses are characterised by substantial statistical heterogeneity, and hence, many summary estimates are uncertain with wide confidence intervals. This heterogeneity is probably caused by heterogeneity in study populations and study design. We have carried out a large number of subgroup analyses aiming to explore what causes the heterogeneity, but it was impossible to single out factors of particular importance. It seems likely that many factors play a role and that the uncertainty would be reduced if we were able to control for confounding variables and present adjusted summary estimates. Unfortunately, this was not possible without access to individual patient data. We did not formally evaluate potential bias that may be caused by use of means and SDs for skewed variables in our analyses of risk factors. Finally, we were unable to include data on economic costs because of missing data.

Strengths of this systematic review are the high number of included studies and patients. Further, the literature search, study selection, and data extraction were determined and published before study start. Two independent collaborators in duplicate screened studies for eligibility, evaluated quality, and extracted data according to pre-set criteria. Finally, we contacted authors twice by e-mail in order to retrieve complete data from eligible publications.

An implication of this systematic review for clinical practice is that health care personnel should be aware of burn patients at risk for AKI, for instance elderly patients with chronic hypertension, diabetes mellitus, and extensive burn injuries. Future studies should explore long-term patient outcomes and treatment costs of AKI among burn victims. There is a clear need for development of uniform standards of reporting in AKI, especially a consensus definition of renal recovery \[[@CR64], [@CR67]\].

Conclusions {#Sec27}
===========

The present systematic review reveals that AKI and use of RRT is common in ICU patients with burn injuries. Patients with high age, chronic hypertension, diabetes mellitus, high TBSA percent burnt, high ABSI score, inhalation injury, rhabdomyolysis, surgery, high APACHE II score, high SOFA score, sepsis, and need for mechanical ventilation are at risk for post-burn AKI. Development of AKI after burn has a negative impact on short-time morbidity and mortality, but we lack data on long-term patient outcomes and economic consequences. Limited data suggests that most survivors of AKI regain their kidney function.
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